343 related articles for article (PubMed ID: 28435226)
1. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
[TBL] [Abstract][Full Text] [Related]
4. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.
Rho CR; Choi JS; Seo M; Lee SK; Joo CK
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5871-9. PubMed ID: 26348636
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
7. Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.
Hos D; Koch KR; Bucher F; Bock F; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6133-42. PubMed ID: 23970469
[TBL] [Abstract][Full Text] [Related]
8. Corneal Collagen Cross-Linking With Riboflavin and UVA Regulates Hemangiogenesis and Lymphangiogenesis in Rats.
Zhu Y; Li L; Reinach PS; Li Y; Ge C; Qu J; Chen W
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3702-3712. PubMed ID: 30029257
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
Lipp M; Bucher F; Parthasarathy A; Hos D; Onderka J; Cursiefen C; Bock F
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):943-9. PubMed ID: 24728466
[TBL] [Abstract][Full Text] [Related]
10. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
11. Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo.
Ischenko I; Seeliger H; Camaj P; Kleespies A; Guba M; Eichhorn ME; Jauch KW; Bruns CJ
Curr Cancer Drug Targets; 2010 Aug; 10(5):546-53. PubMed ID: 20370688
[TBL] [Abstract][Full Text] [Related]
12. Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
García-Caballero M; Blacher S; Paupert J; Quesada AR; Medina MA; Noël A
Br J Pharmacol; 2016 Jun; 173(12):1966-87. PubMed ID: 27018653
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
[TBL] [Abstract][Full Text] [Related]
14. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
[TBL] [Abstract][Full Text] [Related]
15. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
[TBL] [Abstract][Full Text] [Related]
16. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
[TBL] [Abstract][Full Text] [Related]
18. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
19. Integrin Alpha-9 Mediates Lymphatic Valve Formation in Corneal Lymphangiogenesis.
Altiok E; Ecoiffier T; Sessa R; Yuen D; Grimaldo S; Tran C; Li D; Rosner M; Lee N; Uede T; Chen L
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6313-9. PubMed ID: 26431485
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.
Hos D; Saban DR; Bock F; Regenfuss B; Onderka J; Masli S; Cursiefen C
Arch Ophthalmol; 2011 Apr; 129(4):445-52. PubMed ID: 21482870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
